Expanding COVID-19 Vaccine Availability: Role for Combined Orthogonal Serology Testing (COST)
Background: The persisting Coronavirus disease 2019 (COVID-19) pandemic and limited vaccine supply has led to a shift in global health priorities to expand vaccine coverage. Relying on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) molecular testing alone cannot reveal the infection pr...
Main Authors: | Madhusudhanan Narasimhan, Lenin Mahimainathan, Ellen Araj, Andrew E Clark, Kathleen Wilkinson, Sruthi Yekkaluri, Jasmin Tiro, Francesca M Lee, Jyoti Balani, Ravi Sarode, Amit G Singal, Alagarraju Muthukumar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/4/376 |
Similar Items
-
Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines
by: Madhusudhanan Narasimhan, et al.
Published: (2021-06-01) -
Towards Quantitative and Standardized Serological and Neutralization Assays for COVID-19
by: Linhua Tian, et al.
Published: (2021-03-01) -
Seroprevalence of antibodies IgG/IgM anti-T. gondii in women of Coro, Venezuela
by: Saúl-García Yotsabeth, et al.
Published: (2019-06-01) -
Determination of IgG1 and IgG3 SARS-CoV-2 Spike Protein and Nucleocapsid Binding—Who Is Binding Who and Why?
by: Jason K. Iles, et al.
Published: (2022-05-01) -
Study of Serological Toxoplasmosis and Risk Factors Associated with Infection in Women Referred to Labs of Northern Tehran, Iran
by: Fatemeh Ghadamgahi, et al.
Published: (2013-10-01)